—

Johnson & Johnson Innovation - JJDC, Inc.

Q2 2021 13F Holdings

  • Location
    new brunswick, NJ
  • Num holdings

    21

  • Value ($000)

    $978,187

  • Date Filed
    08/03/2021
  • Form type
    13F-HR
  • CIK
    0000924020
  • All SEC filings
  • Note
    Holdings aggregated across “other managers” listed in original SEC filing, see here for detailed holdings broken out by other managers
Compare Q2 2021 to
Select Quarter
Issuer Name
Class
CUSIP
VALUE
%
Shares
Principal
Option Type
F
FATE

FATE THERAPEUTICS, INC.

COM
31189P102
$293.27M
30 %

3,379,064

A
ARWR

ARROWHEAD PHARMACEUTICALS

COM
04280A100
$270.07M
28 %

3,260,869

P
PTGX

PROTAGONIST THERAPEUTICS INC.

COM
74366E102
$109.92M
11 %

2,449,183

C
CVRX

CVRX, INC.

COM
126638105
$97.88M
10 %

3,495,575

L
LEGN

LEGEND BIOTECH CORPORATION

SPONSORED ADS
52490G102
$66.88M
7 %

1,629,173

---

MEIRAGTX HOLDINGS PLC

COM
G59665102
$44.93M
5 %

2,898,550

F
FUSN

FUSION PHARMACEUTICALS INC.

COM
36118A100
$29.66M
3 %

3,670,516

V
VOR

VOR BIOPHARMA, INC.

COM
929033108
$20.04M
2 %

1,074,658

P
PHGE

BIOMX INC.

COM
09090D103
$11.65M
1 %

2,133,402

---

THERAPEUTICS ACQUISITION COR

COM CL A
88339T103
$10.27M
1 %

1,000,000

Rows Per Page
10
  • 10
  • 50
  • 100
1 - 10 of 21